CD8A and neoplasm: Further studies showed that both the total number of TLSs and the numbers of TLS-associated immune cells – including but not limited to follicular helper T cells (TFHs), follicular B cells, mature DCs, and CD8+ T cells – and HEVs were associated with prolonged survival in patients with many different tumour types (9–13).